MedTrace Logo

Efficacy and Safety of Milrinone Versus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension

NCT04391478 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-05-18

No results posted yet for this study

Summary

Compare the effect of milrinone versus sildenafil in treatment of neonates with persistent pulmonary hypertension.

Conditions

  • Persistent Pulmonary Hypertension

Interventions

DRUG

Milrinone

milrinone lactate, 1mg/ml, for intra venous use only

DRUG

Sildenafil

50mg sildenafil citrate/tablet, crushed in water taken by nasogastric tube

Sponsors & Collaborators

  • Rania Ali El-Farrash

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Hour
Max Age
10 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-04-30
Completion
2015-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04391478 on ClinicalTrials.gov